Skip to main content
Download PDF

Short-term effectiveness of the national German quitline for smoking cessation: results of a randomized controlled trial

BMC Public Health volume 24, Article number: 588 (2024) Cite this article

Abstract

Background

The objective of the present study was to examine the short-term effectiveness of the national German quitline for smoking cessation.

Methods

A parallel-group, two-arm, superiority, randomized controlled trial with data collection at baseline and post-intervention (three months from baseline) was conducted. Individuals were randomized to either the intervention group, receiving up to six telephone counselling calls, or the control group, receiving an active control intervention (self-help brochure). The primary outcome was the seven-day point prevalence abstinence at post-assessment. Secondary outcomes included changes in smoking-related cognitions and coping strategies from pre- to post-assessment, the perceived effectiveness of intervention components, and the satisfaction with the intervention.

Results

A total of n = 905 adult daily smokers were assigned to either the intervention group (n = 477) or the control group (n = 428). Intention-to-treat analyses demonstrated that individuals allocated to the telephone counselling condition were more likely to achieve seven-day point prevalence abstinence at post-assessment compared to those allocated to the self-help brochure condition (41.1% vs. 23.1%; OR = 2.3, 95% CI [1.7, 3.1]). Participants who received the allocated intervention in both study groups displayed significant improvements in smoking-related cognitions and coping strategies with the intervention group showing greater enhancements than the control group. This pattern was also found regarding the perceived effectiveness of intervention components and the satisfaction with the intervention.

Conclusion

The present study provides first empirical evidence on the short-term effectiveness of the national German quitline for smoking cessation, highlighting its potential as an effective public health intervention to reduce the burden of disease associated with smoking.

Trial registration

This study is registered in the German Clinical Trials Register (DRKS00025343). Date of registration: 2021/06/07.

Peer Review reports

Introduction

Quitlines or telephone tobacco cessation services have been recognized as an effective public health measure [1]. Evidence suggests that telephone counselling can be a promising solution to reach a large number of the smoking population [2, 3]. Additionally, quitlines can facilitate the dissemination of evidence-based smoking cessation treatments [4, 5] by offering treatment to smokers who do not have the resources or the opportunity to access these in other settings. Overall, tobacco consumption remains one of the leading preventable contributors to both morbidity and mortality worldwide [6]. Beyond its health impact, the economic burden of tobacco-related healthcare expenses and decreased productivity is substantial [7, 8]. National quitlines might have the potential to enhance the availability and accessibility to smoking cessation treatments while maintaining treatment efficacy as well as cost-effectiveness [9,10,11,12].

Counselling by phone represents a delivery format for smokers who prefer therapist contact while alleviating barriers of physically attending a counselling service [13]. Like individual face-to-face behavioral support, telephone counselling can be tailored to the characteristics of the recipient and maximize the level of support around the needs of an individual [10, 13]. Another advantage of quitlines is that they can provide immediate cessation support [14]. Moreover, telephone counselling may be a feasible way to provide individual counselling to underserved groups, such as ethnic minorities [12, 15] or younger people [16, 17]. A recent systematic review, including 104 trials and 111,653 participants, has shown that proactive telephone counselling (calls initiated by a counsellor) for smoking cessation leads to higher rates of achieving abstinence when compared to minimal intervention controls (risk ratio (RR) = 1.25, 95% confidence interval (CI) [1.15 to 1.35]) [10].

Counselling services provided by quitlines have usually applied cognitive behavioral therapy (CBT) and the practice of motivational interviewing (MI) [1, 13, 18,19,20,21]. Components typically included in CBT-based smoking cessation interventions are the identification and change of maladaptive thought and behavior patterns [22, 23], the development of problem-solving and coping skills based on relapse prevention theory [18, 20], and the enhancement of self-efficacy [20, 24]. MI is a client-centered approach, that seeks to strengthen the commitment and the motivation for behavior change through the exploration and resolution of ambivalence between a person’s values and their current behaviors [19]. One study has demonstrated that CBT and MI-based quitline counselling leads to changes in psychological processes [25]. Specifically, it was found that quitline support effectively reduced positive expectations related to smoking outcomes, alleviated negative affect, enhanced self-efficacy, and increased the avoidance of external cues to smoking, while fostering the acceptance of internal cues [25].

In 2003, the World Health Organization (WHO) adopted the WHO Framework Convention of Tobacco Control (WHO FCTC) [26], providing a global response to the health and economic challenges posed by tobacco use. To assist countries in enforcing the comprehensive tobacco control policies described in the FCTC, the technical package called MPOWER was launched [27]. One of the cost-effective demand-reduction elements of the MPOWER strategy is “O – Offer help to quit tobacco use”, for example by enhancing the availability of telephone counselling services [27]. According to the Tobacco Control Scale, which demonstrates the implementation of tobacco control policies at the country level in Europe, Germany ranked among the lowest five countries in 2021 [28]. The establishment of a national quitline, however, represents one of the few proposed measures that have been implemented [28]. The Federal Centre for Health Education oversees the national quitline offering reactive telephone counselling (calls initiated by the smoker) with a maximum of five proactive follow-up calls (calls initiated by the counsellor). Despite its implementation in 1999, the counselling services of the national German Smokers Quitline have not yet been examined empirically. While the implementation of tobacco control policies is necessary, it is equally important to evaluate whether those measures are effective.

In the current study, we aimed to investigate the short-term effects of counselling services of the national German Smokers Quitline on smoking cessation. To accomplish this, we compared the abstinence rates of smokers, who received pro-active telephone counselling with those of smokers who received an active control treatment (i.e., a self-help brochure) three months from baseline (primary outcome). In addition, we investigated these effects on changes in dysfunctional smoking-related cognitions, in self-efficacy, and the acquisition of coping strategies as well as on participants’ perceived effectiveness of intervention components and on their satisfaction with the intervention (secondary outcomes). Based on previous research [10], we expected that participants in the telephone counselling condition would be more likely to achieve abstinence compared to individuals in the control condition. Given that smokers in the control condition received an active control intervention, we hypothesized that smokers in both conditions would show changes in smoking-related cognitions and coping strategies over time but that this effect would be greater for those in the intervention group. Additionally, greater perceived effectiveness of intervention components and satisfaction with the treatment were expected in the intervention group compared with the control group.

Methods

Study design

The present study employed a parallel-group, superiority, two-arm randomized controlled trial (RCT) design. Participants were stratified and randomly assigned to proactive telephone counselling (intervention group) or a self-help brochure (control group). Data collection took place at baseline (t0), as well as three (t1) and twelve months (t2) after baseline assessment. For the current analyses, data from t0 and t1 was considered.

Sample size

To calculate the required sample size, a power analysis was carried out using the software G*Power [21]. Based on previous studies examining the effects of telephone smoking counselling and the use of self-help materials on seven-day-point-prevalence abstinence rates [10], a small effect size was expected. Assuming a significance level of 5% and statistical power of 0.8, the estimated required sample is n = 700 participants. The calculated sample size was corrected by a 30% dropout rate at t2 [7], resulting in a total sample size of n = 910 enrolled participants.

Procedure

Participants were recruited by a market research company from October 2021 to July 2022 using face-to-face interviews, social media (Instagram and Facebook), and the PAYBACK panel. PAYBACK is the country’s largest customer loyalty program used by approximately half of German households. Its panel consists of over 130,000 adults, being one of Germany’s largest online access panels. Information about the study, along with a link to a digital screening survey, was provided to individuals either via email or directly through advertising. Individuals who had a minimum age of 18 years, reported having smoked at least one cigarette per day within the past 30 days, intended to quit smoking within the next four weeks, and wanted to participate in a research study were deemed eligible. A link to the baseline questionnaire (t0) and a personal identifier were sent to eligible individuals via email. The baseline assessment included an overview of the study and participants were asked to provide informed consent digitally. Once consent was obtained, participants completed the questionnaire on socio-demographics and smoking-related behavior.

Individuals who provided informed consent, completed the questionnaire and met the inclusion criteria once again were stratified and randomized in a 1:1 allocation ratio to one of the two study groups. Stratification was based on four criteria: (a) number of cigarettes smoked per day (1–10, 11–20, 21–30, > 30), (b) sex (female, male, non-binary), (c) age (18–30, 31–64, > 64), and (d) educational level (low, middle, high; [29]). Following the randomization procedure, participants were informed by email to which group they had been assigned and received the respective intervention no longer than two weeks after randomization. Individuals in the intervention group were contacted up to three times by the telephone counsellors to start the intervention and participants in the control group were called a maximum of five times by the study team to confirm receiving the self-help brochure. If necessary, the brochure was re-sent.

Three months after the baseline assessment, participants were invited by email to complete the post-questionnaire (t1). In case of non-response, the study team sent a maximum of two reminder emails and called once to encourage completion. Participants could earn up to 40€ for completing both questionnaires. For more detailed information, see the study protocol [30].

Interventions

Proactive telephone counselling

The national German quitline for smoking cessation provides telephone counselling to smokers who want to quit smoking soon (i.e., in the next two weeks). The counselling protocol covers two phases of smoking cessation: preparing to quit (one session) and the maintenance of smoking cessation and relapse prevention after quitting (up to five sessions afterward). The counselling process is structured but can be tailored to individual circumstances and is based on the California Smokers’ Helpline protocol [13]. It combines MI and cognitive-behavioral approaches to help clients change their behavior [13]. The initial session (intake session) focuses on evaluating their smoking history, their smoking patterns, and their motivation to quit. The counsellor's objectives are to address any ambivalence, reinforce self-efficacy and motivation, identify challenging situations, and establish coping mechanisms. Additionally, the counsellor and the participant agree on a quit date within a 14-day timeframe. Follow-up calls are offered for maintaining smoking cessation as well as relapse prevention and take place at different intervals after the quit date. For more detailed information, see the study protocol [30].

Self-help brochure

Participants in the control condition received a non-tailored self-help brochure titled ‘Ja, ich werde rauchfrei!’ [‘Yes, I’ll be smoke-free!’], provided by the Federal Centre for Health Education [31]. The 92-page booklet complies with the principles of CBT and directs readers through the process of quitting smoking and maintaining abstinence [18]. It covers topics such as understanding smoking and quitting, preparing for cessation, and approaches to sustain abstinence (e.g., using coping techniques). The uptake of the brochure was self-directed. For more detailed information, see the study protocol [30].

Measures

Sample characteristics at baseline

At baseline, socio-demographic data including age, gender, nationality, employment status, marital status and living situation were assessed. Additionally, information on the years of smoking, cigarettes smoked per day, cigarette dependence (FTCD; [32]), numbers of quit attempts in the past, the most recent quit attempt, the use of smoking cessation aids of former quit attempts, the importance and confidence to quit (assessed on visual analogue scales ranging from 0 (not at all important/confident) to 100 (very important/confident)) and the presence of smoking-related chronic respiratory illnesses was gathered.

Use of the interventions

In the intervention group, participants were asked about the number of telephone counselling calls they had received (maximum six calls). In the control group, individuals reported whether they received the self-help brochure and, if so, the extent to which they had read it. Response options ranged from “very little”, “less than half”, “more than half” to “completely” [33].

Seven-day point prevalence abstinence

The primary outcome was the seven-day point prevalence abstinence (yes/no) at t1. Individuals who had smoked cigarettes, even a single puff, or reported consuming any other type of tobacco products in the past seven days were classified as smokers.

Changes in smoking-related cognitions and coping strategies

The self-efficacy to refrain from smoking, positive smoking outcome expectancies, avoidance of external cues, and perceived control over withdrawal symptoms were assessed at t0 and t1.

Self-efficacy to refrain from smoking

Participants were presented with twelve different situations, such as “When you are with friends who smoke” and were asked to rate the level of difficulty of refraining from smoking in each situation [25, 34, 35]. A 5-point Likert scale was used ranging from 1 (very easy) to 5 (very difficult). Values were recoded so that a higher mean score indicated higher self-efficacy to refrain from smoking. Cronbach’s alpha was 0.82.

Positive smoking outcome expectancies

Participants were requested to indicate their degree of agreement with ten statements related to smoking, such as “Smoking helps calming down”, retrieved from the Pros of Smoking Scale [25, 36]. They provided their responses on a 5-point Likert scale, ranging from 1 (totally disagree) to 5 (totally agree). A lower mean score reflected a lower perception of smoking as being beneficial. Cronbach’s alpha was 0.76.

Avoidance of external cues

Participants were asked about the frequency of employing strategies to avoid external cues for smoking. Four items, such as “I remove things from my home that remind me of smoking” were used. These were rated on 5-point Likert scales ranging from 1 (never) to 5 (very often) and were derived from the stimulus control and counter-conditioning subscales of the Process of Change [25, 37]. A higher mean score indicated a greater utilization of strategies to avoid smoking-related external cues. Cronbach’s alpha was 0.75.

Perceived control over withdrawal symptoms

Perceived control over withdrawal symptoms was assessed using four items, such as “I believe that I am capable of dealing adequately with withdrawal symptoms from smoking” [38, 39]. Each statement was evaluated using a 5-point Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). A higher mean score reflected a greater perception of control over withdrawal symptoms. Cronbach’s alpha was 0.91.

Perceived effectiveness of intervention components and satisfaction with the intervention

Participants in both study groups evaluated intervention components by indicating the helpfulness of the intervention regarding their motivation to quit/to maintain non-smoking, their management of withdrawal symptoms, their handling of strong cigarette cravings, their management of triggering situations, and their prevention of lapse/relapse [33]. Answer categories were “did not help”, “helped a little”, or “helped a lot”. Additionally, participants expressed their level of satisfaction regarding the duration of the intervention (“too short”, “about right”, or “too long”). The overall satisfaction with telephone counselling/the self-help brochure was measured using the answer categories “very unsatisfied”, “unsatisfied”, “satisfied”, or “very satisfied”. Participants were further asked if they would recommend the intervention (yes/no) and about their willingness (yes/no) to use the telephone counselling services again if needed (intervention group only) [33].

Statistical analysis

Descriptive statistics (means, standard deviations and frequencies) were obtained for sample characteristics at baseline in the intention-to-treat (ITT) sample, which consisted of all randomized participants. The use of the intervention was described for individuals in the complete case (CC) sample, characterized by participants who received their allocated intervention and completed both questionnaires (t0 and t1). The ITT sample and the CC sample were compared in terms of baseline characteristics using unpaired t-tests and χ2-tests. This approach was further employed to compare the treatment groups within both sample sets.

Abstinence was analyzed for the ITT and the CC sample. According to the Russell standard, participants with missing information on their smoking status were classified as smokers [40]. The odds ratios (ORs) and corresponding 95% confidence intervals (CIs) of abstinence (vs. non-abstinence) based on group assignment were examined using binary logistic regressions. The secondary outcomes could only be analyzed for the CC sample, which consists of participants who provided those data in the t1 questionnaire. Mixed-repeated measurement Analyses of Variance (ANOVAs) were conducted to examine the impact of the intervention on changes in smoking-related cognitions and coping strategies. Post-hoc tests were performed using one-sided paired and one- (t1) and two-sided (t0) unpaired t-tests. To compare differences between groups in the perceived effectiveness of intervention components and the satisfaction with the intervention, χ2-tests were applied. The significance level was set to p = 0.05 for all statistical analyses. Data analyses were conducted using R version 4.3.0 [41, 42].

Results

Sample characteristics at baseline

A total of n = 905 participants were randomized (ITT sample). Of those, n = 675 completed the post-assessment (Fig. 1) and n = 653 received their allocated intervention (CC sample). Descriptive statistics for baseline characteristics of the ITT sample are displayed in Table 1. No significant differences were observed for any of the assessed variables between the ITT and CC samples, for both the entire sample and the treatment groups. Additionally, no significant differences were found between participants in the intervention group and the control group in both sets of samples.

Fig. 1
figure 1

Flowchart of participants

Full size image
Table 1 Sample characteristics at baseline
Full size table

Attrition

To assess attrition, we conducted χ2-tests for categorical variables and unpaired t-tests for continuous variables to compare baseline characteristics between participants lost to follow- up and those who completed the questionnaire at t1. At t1, n = 310 participants (88.1%) completed the questionnaire in the telephone counselling group, while n = 365 participants (85.3%) completed the questionnaire in the control group. There was no significant difference in attrition between study groups (χ2(1) = 1.06, p = 0.303). An analysis comparing participants lost at t1 with those remaining on all baseline characteristics revealed a significant difference in German citizenship (χ2(1) = 6.06, p = 0.014). More participants without German citizenship were lost to follow-up compared to those with German citizenship. Additionally, participants lost at t1 had a significantly higher daily cigarette use at baseline (M = 17.5) compared to the remaining participants (M = 15.9, t(787) = 2.07, p = 0.039). No significant differences were observed within the study conditions on the assessed variables.

Use of the interventions

Participants in the intervention group received on average 4.0 (SD = 1.6, R = 1 – 6) telephone counselling calls. Among individuals in the control condition, the majority read the brochure completely (56.9%) or at least half of it (31.0%). In total, 10.1% read less than half of the brochure and 2.0% read very little of the brochure.

Seven-day point prevalence abstinence

In the ITT sample, the intervention group demonstrated a higher seven-day point prevalence abstinence rate compared to the control group with rates of 41.1% vs. 23.1%, respectively. The odds for seven-day point prevalence abstinence were significantly higher (OR = 2.3, 95% CI [1.7, 3.1]) for the intervention group in comparison with the control group. The CC sample yielded seven-day point prevalence abstinence rates of 63.9% in the intervention group and 28.4% in the control group. Significant higher odds (OR = 4.5, 95% CI [3.2, 6.2]) for seven-day point prevalence abstinence were found for the intervention group compared to the control group.

Sensitivity analyses

To determine the robustness of the findings, abstinence was additionally defined as no use of any tobacco products or alternative products [43]. Moreover, we accounted for randomization strata and calculated adjusted and unadjusted ORs for abstinence. The findings remained consistent when considering abstinence from alternative products as part of the outcome or adjusting for randomization strata.

Changes in smoking-related cognitions and coping strategies

There was a significant group × time interaction effect on self-efficacy to refrain from smoking (F(1, 651) = 54.32, p < 0.001), positive smoking outcome expectancies (F(1, 651) = 23.52, p < 0.001), avoidance of external cues (F(1, 651) = 10.74, p = 0.001) and perceived control over withdrawal symptoms (F(1, 651) = 40.44, p < 0.001). No significant inter-group differences were found at baseline regarding the self-efficacy to refrain from smoking (t(651) = -0.48, p = 1.00), positive smoking outcome expectancies (t(651) = -0.41, p = 1.00), avoidance of external cues (t(651) = -1.46, p = 0.291) and perceived control over withdrawal symptoms (t(651) = 0.59, p = 1.00). At post-assessment, the intervention group demonstrated significantly greater self-efficacy to refrain from smoking (t(651) = 6.57, p < 0.001), lower positive smoking outcome expectancies (t(651) = 4.23, p < 0.001), higher avoidance of external cues (t(651) = -4.98, p < 0.001) and higher perceived control over withdrawal symptoms (t(651) = -6.05, p < 0.001) compared to the control group. Significant intra-group differences from t0 to t1 were found in all the assessed psychological constructs for both groups (Table 2).

Table 2 Means, standard deviations, and t-test statistics for changes in smoking-related cognitions and coping strategies
Full size table

Perceived effectiveness of intervention components and satisfaction with the intervention

Compared with the control group, participants in the intervention group reported significantly higher perceived effectiveness of the intervention components: their motivation to quit, the management of their withdrawal symptoms, strong cravings, situations that trigger craving, and the prevention of lapse/relapse (Table 3).

Table 3 Frequencies and chi-square results for the perceived effectiveness of intervention components
Full size table

Individuals in the intervention group expressed significantly higher satisfaction regarding both the intervention’s duration and the overall intervention when compared to those in the control group (Table 4).

Table 4 Frequencies and chi-square results for the satisfaction with the intervention
Full size table

No significant differences between groups were found regarding the participants’ recommendation of the intervention to others (intervention group = 84.9%, control group = 80.7%, χ2(1) = 1.70, p = 0.193). Additionally, 76.4% of individuals in the intervention group expressed their willingness to contact the quitline again if needed.

Discussion

The present study examined the short-term effectiveness of the national German quitline for smoking cessation using a two-arm RCT comparing the counselling services to a self-help brochure. As expected, proactive telephone counselling outperformed the support of a self-help brochure, with a greater likelihood of seven-day point prevalence abstinence three months from baseline. The telephone counselling's superiority may be attributed to its ability to provide personalized support tailored to an individual's specific requirements [10, 13] in contrast to a non-tailored self-help brochure. Moreover, although the self-help brochure also followed CBT principles, CBT has been demonstrated to yield more substantial effects when supplemented with guidance, for example from a counsellor [44, 45]. Lastly, a comprehensive approach that combines elements of CBT and MI has been shown to be more effective in supporting smoking cessation compared to solely using CBT [46].

The current result aligns with prior research, indicating that proactive telephone counselling for smoking cessation yields greater abstinence rates when compared to minimal intervention controls [10]. However, the present smoking cessation rates in both conditions were higher than those in previous studies [10, 21, 47]. For example, the European Smoking Cessation Helplines Evaluation study (ESCHER) focused on evaluating national quitline usage and its impact on smoking cessation rates across multiple European countries [21]. Across countries, an overall seven-day point prevalence abstinence rate of 14.3% was reported among individuals who were preparing to quit and received quitline counselling. Regarding the effectiveness of printed self-help resources for smoking cessation, a meta-analysis demonstrated abstinence rates ranging from 2 to 10% [47].

The disparity in cessation rates in comparison with previous studies might be explained by the time-point of abstinence assessment and the included samples. Compared to the three-month post-assessment in the current study, previous studies [10, 21, 47] evaluated abstinence at least six months after the intervention. Although relapses are most common within the first five to ten days of a quit attempt, they are still likely to occur in the following months [48]. Abstinence rates for both groups in the present study are therefore expected to decrease over time. The difference in abstinence rates between the current study and previous research might also be attributed to differences in the study samples. In the current study, participants were eligible to participate if they intended to quit smoking within the next four weeks. This eligibility criterion was less strict in prior research [10]. However, the intention to quit smoking was identified as a predictor of quit attempts [49, 50], possibly explaining the higher abstinence rates in the current study.

As expected, both study groups demonstrated significant enhancements in smoking-related cognitions and coping strategies. Nevertheless, individuals who received quitline counselling reported greater self-efficacy to refrain from smoking, less positive smoking outcome expectancies, higher avoidance of external cues and higher perceived control over withdrawal symptoms than participants who read the self-help brochure. Those greater enhancements in the telephone group may be attributed to the structured, individually tailored counselling using evidence-based elements of CBT and MI targeting those psychological processes. However, the content of the brochure was also based on elements of CBT, possibly explaining the found improvements in the control condition over time. By including CBT-based strategies like cognitive reorganization to target unhelpful thought patterns, the content of the brochure intended to target the same psychological processes.

The same pattern of results was found regarding the participants’ perceived effectiveness of intervention components and their satisfaction with the intervention. In both groups, more than half of the participants perceived the intervention components as at least a little helpful with regard to their motivation to quit, their ability to manage withdrawal symptoms, their ability to manage strong cravings for cigarettes and situations that trigger strong cravings, as well as with their ability to prevent lapses or relapses. However, the individuals in the telephone counselling condition perceived the intervention as more helpful and were more satisfied with the intervention than the participants in the control condition.

This study holds significant implications. Of German smokers making an annual attempt to quit smoking (19.9%), only 13.0% use evidence-based strategies [51]. While methods like brief consultations with physicians and over-the-counter nicotine replacement therapy are used most often (5.3% and 4.9%, respectively), merely 0.8% of individuals turn to quitlines for support [51]. Given the short-term effectiveness of the German national quitline for smoking cessation and its potential for long-term effectiveness, future research should investigate the factors that contribute to its underutilization.

Literature suggests that barriers to smoking cessation treatments possibly include the cost of treatment, a lack of awareness regarding the availability of cessation support and a reduced interest in conventional approaches [52,53,54]. As the national German quitline for smoking cessation offers telephone counselling free of charge, the cost of treatment does not constitute a barrier in Germany. However, future research needs to examine smokers’ awareness of the existence of the national quitline and its services and possibly increase its promotion or adapt promotion strategies.

A reduced interest in conventional smoking cessation interventions and a personal preference for a certain type of intervention emphasize that telephone counselling should supplement other forms of smoking cessation counselling. The results of the current study confirm that quitline counselling should be an important part of public health provision [20]. While quitlines may produce lower abstinence rates compared to clinical interventions, as a public health approach, they can cast a wider net to reach a larger number of smokers [20, 55] and, therefore, may have a greater potential to reduce rates of morbidity and mortality [56]. Considering that evidence-based treatments provided through national quitlines have been well-established in alternative formats, such as face-to-face individual or group therapy for smoking cessation [20, 57, 58], quitline counselling should be one element in a comprehensive stepped-care strategy of smoking cessation support. To accommodate the diverse needs and preferences of smokers, a range of support options should be available, offering varying levels of intensity and degrees of anonymity.

The results presented are subject to limitations. First, the present sample differs from callers to the national German quitline for smoking cessation and recipients of pro-active follow-up calls with regard to socio-demographic and smoking-related variables [59]. Consequently, the external validity of the results is somewhat limited. Although this could have been accounted for by including only individuals in the study who called the quitline, randomizing callers to the control condition would have been ethically inappropriate. Second, using self-reported data to assess abstinence may have led to an overestimation of actual abstinence rates [60]. Nevertheless, biochemical validation in smoking cessation research may not be necessary and the misrepresentation of the smoking status is considered rare [61]. Third, the current study examined the short-term effectiveness of telephone counselling services. However, evidence on the long-term effectiveness is needed to ascertain sustainability of the treatment effects [40]. Results on whether the counselling services of the national German quitline for smoking cessation leads to long-term abstinence will be published once data analysis is completed.

This study demonstrates that the national German quitline for smoking cessation is effective in the short term. In addition to the high abstinence rates, the positive changes in intervention targets and the participants’ satisfaction with the telephone counselling highlights the potential of the provided services to curb smoking addiction and reduce the associated burden of disease. The present findings carry implications for public health policy, indicating that the availability and the promotion of telephone counselling services could serve as a valuable strategy for augmenting smoking cessation initiatives in Germany.

Availability of data and materials

Anonymized study data and statistical codes to analyses may be made available on request from the corresponding author following study closure.

Abbreviations

ANOVA:

Analysis of Variance

BZgA:

Bundeszentrale für gesundheitliche Aufklärung, Federal Centre for Health Education

CBT:

Cognitive behavioral therapy

CC:

Complete case

CI:

Confidence interval

CONSORT:

Consolidated Standards for Reporting Trials

DGP:

Deutsche Gesellschaft für Psychologie, German Psychological Society

DRKS:

Deutsches Register klinischer Studien

FCTC:

Framework Convention on Tobacco Control

FTCD:

Fagerström Test for Cigarette Dependence

IFT:

Institut für Therapieforschung

ITT:

Intention-to-treat

MI:

Motivational interviewing

RCT:

Randomized controlled trial

RR:

Risk ratio

WHO:

World Health Organization

References

  1. Anderson CM, Zhu S-H. Tobacco quitlines: looking back and looking ahead. Tob Control. 2007;16(Suppl 1):i81–6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Fiore MC. US public health service clinical practice guideline: treating tobacco use and dependence. Respir Care. 2000;45(10):1200–62.

    CAS  PubMed  Google Scholar 

  3. Zhu SH, Anderson CM, Tedeschi GJ, Rosbrook B, Johnson CE, Byrd M, Gutiérrez-Terrell E. Evidence of real-world effectiveness of a telephone quitline for smokers. N Engl J Med. 2002;347(14):1087–93.

    Article  PubMed  Google Scholar 

  4. Abrams DB, Graham AL, Levy DT, Mabry PL, Orleans CT. Boosting population quits through evidence-based cessation treatment and policy. Am J Prev Med. 2010;38(3):S351–63.

    Article  PubMed  PubMed Central  Google Scholar 

  5. McAfee TA. Quitlines: a tool for research and dissemination of evidence-based cessation practices. Am J Prev Med. 2007;33(6):S357–67.

    Article  PubMed  Google Scholar 

  6. Reitsma MB, Kendrick PJ, Ababneh E, Abbafati C, Abbasi-Kangevari M, Abdoli A, et al. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet. 2021;397(10292):2337–60.

    Article  Google Scholar 

  7. Schaller K, Kahnert S, Graen L, Mons U, Ouedraogo N. Tabakatlas Deutschland 2020. Lengerich/Westfalen: Pabst Science Publishers; 2020.

    Google Scholar 

  8. Goodchild M, Nargis N, Tursan DE. Global economic cost of smoking-attributable diseases. Tob Control. 2018;27(4):58–64.

    Article  PubMed  Google Scholar 

  9. Hollis JF, McAfee TA, Fellows JL, Zbikowski SM, Stark M, Riedlinger K. The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Toba Control. 2007;16:i53-9.

    Article  Google Scholar 

  10. Matkin W, Ordóñez-Mena JM, Hartmann-Boyce J. Telephone counselling for smoking cessation. Cochrane Database Syst Rev. 2019;2019(5):CD002850.

    PubMed Central  Google Scholar 

  11. US Department of Health and Human Services. Smoking cessation: a report of the Surgeon General. Atlanta: US Department of Health and Human Services; 2020.

    Google Scholar 

  12. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews. 2013;2013(8).

  13. Zhu S-H, Tedeschi GJ, Anderson CM, Pierce JP. Telephone counseling for smoking cessation: What’s in a call? J Couns Dev. 1996;75(2):93–102.

    Article  Google Scholar 

  14. Zhu SH. Telephone quitlines for smoking cessation. In: National Cancer Institute. Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph. 2000;12:189–98.

  15. Zhu SH, Anderson CM, Johnson CE, Tedeschi G, Roeseler A. A centralised telephone service for tobacco cessation: the California experience. Tob Control. 2000;9:Ii48-55.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chan SS, Wong DC, Fong DY, Leung AY, Lam DO, Mak YW, Lam TH. The establishment and promotion of the first Youth Quitline in Hong Kong: challenges and opportunities. Eval Health Prof. 2008;31(3):258–71.

    Article  PubMed  Google Scholar 

  17. Gilbert H, Sutton S, Sutherland G. Who calls QUIT? The characteristics of smokers seeking advice via a telephone helpline compared with smokers attending a clinic and those in the general population. Public Health. 2005;119(10):933–9.

    Article  CAS  PubMed  Google Scholar 

  18. Marlatt GA, Gordon JR. Relapse prevention: Maintenance strategies in the treatment of addictive behaviors. 1st ed. New York: The Guilford Press; 1985.

    Google Scholar 

  19. Miller WR, Rollnick S. Motivational interviewing: Preparing people for change. 2nd ed. New York, NY, US: The Guilford Press; 2002.

    Google Scholar 

  20. Vidrine JI, Cofta-Woerpel L, Daza P, Wright KL, Wetter DW. Smoking cessation 2: Behavioral Treatments. Behav Med. 2006;32(3):99–109.

    Article  PubMed  Google Scholar 

  21. Willemsen M, Van der Meer R, Bot SM. Description, effectiveness, and client satisfaction of 9 European Quitlines: Results of the European Smoking Cessation Helplines Evaluation Project (ESCHER). 2008.

    Google Scholar 

  22. Vinci C. Cognitive behavioral and mindfulness-based interventions for smoking cessation: a review of the recent literature. Curr Oncol Rep. 2020;22(6):58.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Nathan PE, Gorman JM. A guide to treatments that work. Oxford: Oxford University Press; 2015.

    Book  Google Scholar 

  24. Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J. Treatment of Tobacco Smoking: A Review. JAMA. 2022;327(6):566–77.

    Article  PubMed  Google Scholar 

  25. Schuck K, Otten R, Kleinjan M, Bricker JB, Engels RC. Self-efficacy and acceptance of cravings to smoke underlie the effectiveness of quitline counseling for smoking cessation. Drug Alcohol Depend. 2014;142:269–76.

    Article  PubMed  Google Scholar 

  26. World Health Organization. WHO framework convention on tobacco control. Geneva: World Health Organization; 2003.

    Google Scholar 

  27. World Health Organization. WHO report on the global tobacco epidemic, 2023: protect people from tobacco smoke. Geneva: World Health Organization; 2023.

    Google Scholar 

  28. Joossens L, Olefir L, Feliu A, Fernandez E. The Tobacco Control Scale 2021 in Europe. Brussels: Smoke Free Partnership, Catalan Institute of Oncology; 2022. Available from: https://www.tobaccocontrolscale.org/TCS2021.

  29. OECD, Eurostat, UNESCO Institute for Statistics. ISCED 2011 operational manual: guidelines for classifying national education programmes and related qualifications. 2015.

    Book  Google Scholar 

  30. Delle S, Kraus L, Maspero S, Pogarell O, Hoch E, Lochbühler K. Effectiveness of the national German quitline for smoking cessation: study protocol of a randomized controlled trial. BMC Public Health. 2022;22(1):1386.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Bundeszentrale für gesundheitliche Aufklärung: Ja, ich werde rauchfrei! Eine praktische Anleitung zu für Ihren Weg zum Rauchstopp. Köln, Germany: Bundeszentrale für gesundheitliche Aufklärung; 2021

  32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119–27.

    Article  CAS  PubMed  Google Scholar 

  33. Schuck K, Otten R, Kleinjan M, Bricker JB, Engels RC. School-based promotion of cessation support: reach of proactive mailings and acceptability of treatment in smoking parents recruited into cessation support through primary schools. BMC Public Health. 2013;13:381.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271–83.

    Article  CAS  PubMed  Google Scholar 

  35. Etter JF, Bergman MM, Humair JP, Perneger TV. Development and validation of a scale measuring self-efficacy of current and former smokers. Addiction. 2000;95(6):901–13.

    Article  CAS  PubMed  Google Scholar 

  36. Dijkstra A, De Vries H, Bakker M. Pros and cons of quitting, self-efficacy, and the stages of change in smoking cessation. J Consult Clin Psychol. 1996;64:758–63.

    Article  CAS  PubMed  Google Scholar 

  37. Prochaska JO, Velicer WF, DiClemente CC, Fava J. Measuring processes of change: applications to the cessation of smoking. J Consult Clin Psychol. 1988;56(4):520–8.

    Article  CAS  PubMed  Google Scholar 

  38. Martinez E, Tatum KL, Glass M, Bernath A, Ferris D, Reynolds P, Schnoll RA. Correlates of smoking cessation self-efficacy in a community sample of smokers. Addict Behav. 2010;35(2):175–8.

    Article  PubMed  Google Scholar 

  39. Schnoll RA, Martinez E, Tatum KL, Glass M, Bernath A, Ferris D, Reynolds P. Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment. Addict Behav. 2011;36(1–2):144–7.

    Article  PubMed  Google Scholar 

  40. West R, Hajek P, Stead LF, Stapleton J. Assessing smoking cessation performance in NHS stop smoking services: the Russell standard (clinical). Addiction. 2005;100(3):299–303.

    Article  PubMed  Google Scholar 

  41. R Core Team. R: A language and environment for statistical computing. Vienna: 2023. https://www.R-project.org/.

  42. RStudio team. RStudio: integrated development for R. Boston: 2020. http://www.rstudio.com/.

  43. Piper ME, Bullen C, Krishnan-Sarin S, Rigotti NA, Steinberg ML, Streck JM, Joseph AM. Defining and measuring abstinence in clinical trials of smoking cessation interventions: an updated review. Nicotine Tob Res. 2020;22(7):1098–106.

    Article  PubMed  Google Scholar 

  44. Cuijpers P, Noma H, Karyotaki E, Cipriani A, Furukawa TA. Effectiveness and acceptability of cognitive behavior therapy delivery formats in adults with depression: a network meta-analysis. JAMA Psychiat. 2019;76(7):700–7.

    Article  Google Scholar 

  45. Newman MG, Szkodny LE, Llera SJ, Przeworski A. A review of technology-assisted self-help and minimal contact therapies for drug and alcohol abuse and smoking addiction: Is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011;31(1):178–86.

    Article  PubMed  Google Scholar 

  46. Melnick R, Mendonça CS, Meyer E, Faustino-Silva DD. Effectiveness of motivational interviewing in smoking groups in primary healthcare: a community-based randomized cluster trial. Cad Saude Publica. 2021;37(3):e00038820.

    Article  PubMed  Google Scholar 

  47. Lancaster T, Stead LF. Self-help interventions for smoking cessation. Cochrane Database Syst Rev. 2005;(3):CD001118. PMID: 12137618.

  48. Piasecki TM. Relapse to smoking. Clin Psychol Rev. 2006;26(2):196–215.

    Article  MathSciNet  PubMed  Google Scholar 

  49. Hyland A, Borland R, Li Q, Yong HH, McNeill A, Fong GT, et al. Individual-level predictors of cessation behaviours among participants in the International Tobacco Control (ITC) Four Country Survey. Tob Control. 2006;15(suppl 3):iii83–94.

    PubMed  PubMed Central  Google Scholar 

  50. Smit ES, Fidler JA, West R. The role of desire, duty and intention in predicting attempts to quit smoking. Addiction. 2011;106(4):844–51.

    Article  PubMed  Google Scholar 

  51. Kotz D, Batra A, Kastaun S. Rauchstoppversuche und genutzte Entwöhnungsmethoden. Dtsch Arztebl Int. 2020;117(1–2):7–13.

    PubMed  PubMed Central  Google Scholar 

  52. Bricker J, Wyszynski C, Comstock B, Heffner JL. Pilot randomized controlled trial of web-based acceptance and commitment therapy for smoking cessation. Nicotine Tob Res. 2013;15(10):1756–64.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Husten CG. A Call for ACTTION: Increasing access to tobacco-use treatment in our nation. Am J Prev Med. 2010;38(3 Suppl):S414–7.

    Article  PubMed  Google Scholar 

  54. Sheffer CE, Brackman SL, Cottoms N, Olsen M. Understanding the barriers to use of free, proactive telephone counseling for tobacco dependence. Qual Health Res. 2011;21(8):1075–85.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Gilbert H, Sutton S. Evaluating the effectiveness of proactive telephone counselling for smoking cessation in a randomized controlled trial. Addiction. 2006;101(4):590–8.

    Article  PubMed  Google Scholar 

  56. Lichtenstein E, Glasgow RE. Smoking cessation: what have we learned over the past decade? J Consult Clin Psychol. 1992;60(4):518–27.

    Article  CAS  PubMed  Google Scholar 

  57. Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD001007. https://doi.org/10.1002/14651858.CD001007.pub3.

  58. Vance L, Glanville B, Ramkumar K, Chambers J, Tzelepis F. The effectiveness of smoking cessation interventions in rural and remote populations: Systematic review and meta-analyses. Int J Drug Policy. 2022;106:103775.

    Article  PubMed  Google Scholar 

  59. Lindinger P, Strunk M, Nübling M, Lang P. Arbeitsweise und Wirksamkeit einer Telefonberatung für Tabakentwöhnung. SUCHT. 2012;58(1):33–43.

    Article  Google Scholar 

  60. Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11(1):12–24.

    Article  PubMed  Google Scholar 

  61. Benowitz NL, Iii PJ, Ahijevych K, Jarvis MJ, Hall S, LeHouezec J, et al. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149–59.

    Article  Google Scholar 

  62. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.

    Article  Google Scholar 

  63. World Medical Association (WMA). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.

    Article  Google Scholar 

Download references

Acknowledgements

We thank Cerner Diamond (Constanze Cholmakow-Bodechtel and Martin Ebert) for supporting the recruitment of study participants. We thank Hanna Applis, Christian Becher and Andreas Schimm for supporting data collection and management.

Funding

This trial is funded by the Federal Centre for Health Education (BZgA) on behalf of the German Ministry of Health (Z2/21.21.11/20). This funding source had no role in the design of this study and did not have any role during its execution, analyses, interpretation of the data, or decision to submit results.

Author information

Authors and Affiliations

  1. IFT Institut für Therapieforschung, Centre for Mental Health and Addiction Research, Munich, Germany

    Simona Maspero, Simone Delle, Eva Hoch & Kirsten Lochbühler

  2. Department of Public Health Science, Centre for Social Research On Alcohol and Drugs, Stockholm University, Stockholm, Sweden

    Ludwig Kraus

  3. Institute of Psychology, ELTE Eötvös Loránd University, Budapest, Hungary

    Ludwig Kraus

  4. Centre of Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

    Ludwig Kraus

  5. Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany

    Oliver Pogarell & Eva Hoch

  6. Department Health and Sport Sciences, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany

    Joachim Bachner

  7. Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany

    Kirsten Lochbühler

Authors
  1. Simona Maspero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simone Delle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ludwig Kraus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oliver Pogarell
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eva Hoch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joachim Bachner
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kirsten Lochbühler
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

SD, KL and LK designed the study. SD, SM, KL and LK did the conceptional work. SM and SD conducted the statistical analyses. SM wrote a first draft of the manuscript. SD, KL, LK, EH, OP and JB revised the manuscript. All authors approved the final version of the manuscript for publication.

Corresponding author

Correspondence to Kirsten Lochbühler.

Ethics declarations

Ethics approval and consent to participate

This study has been approved by the Ethics Committee of the German Psychological Society (DGP). It follows the Consolidated Standards of Reporting Trials (CONSORT; [62]) and complies with the principles stipulated in the Declaration of Helsinki [63]. The study is registered in the German Clinical Trials Register (DRKS) public database (trial registration number DRKS00025343, date of registration: 2021/06/07). All substantial protocol deviations or modifications were communicated to the Ethics Committee and the DRKS. Upon enrollment, participants provided written informed consent. The consent form will be provided on request.

Consent for publication

Not applicable. The study results will be presented at conferences and will be submitted for publication in relevant journals.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Maspero, S., Delle, S., Kraus, L. et al. Short-term effectiveness of the national German quitline for smoking cessation: results of a randomized controlled trial. BMC Public Health 24, 588 (2024). https://doi.org/10.1186/s12889-024-18104-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-024-18104-w

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us